- RETRACTED ARTICLE: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB
Yuanchang Hu et al, 2018, Cell Death & Disease CrossRef - Hsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1
Yuxia Wang et al, 2021, Journal of Oncology CrossRef - Promising therapeutic role of miR-27b in tumor
Li Ding et al, 2017, Tumor Biology CrossRef - MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma
Lina Cheng et al, 2017, Digestive Diseases and Sciences CrossRef - Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling
Jingyuan Wen et al, 2022, Cellular & Molecular Biology Letters CrossRef - HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development
Devis Pascut et al, 2021, Cancers CrossRef - microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection
Geneviève.F. Desrochers et al, 2022, Journal of Biological Chemistry CrossRef - LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma
Chang Liu et al, 2024, Journal of Biological Chemistry CrossRef - Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axis
Feifei Wei et al, 2020, Cancer Medicine CrossRef - Expression and effect of miR‑27b in primary liver cancer
Lijuan Zhuo et al, 2023, Oncology Letters CrossRef - HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
Y J Jia et al, 2018, Leukemia CrossRef